Is double autologous transplantation in multiple myeloma superior in the age of new agents?
The stories behind the advances in polycythemia vera
MPN Landmark studies: looking at the disparities in perceptions of disease and treatment preferences
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Francesco Lo Coco
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?